Oncosil Medical Ltd has released a press release.
Prospectus - Entitlement Offer
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from OncoSil Medical
- Placement and Entitlement Offer to raise up to $7.1 million
- 84 German hospitals can negotiate fee for Oncosil device
- OncoSil receives $1.1m R&D tax incentive
- First two commercial patient treatments in Greece
- OncoSil onboards first patient in PANCOSIL Clinical Trial
Later from OncoSil Medical
- First Austria-based treatments utilising the OncoSil device
- First patient treated in the UK for the TRIPP-FXX study
- First patient treated with OncoSil device in Turkiye
- 1st Study in Man Increases Pancreatic Tumor Vascularity
- $5.3 million raised under Entitlement Offer
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical